Neurocysticercosis in Iran: An Unexpected Case and Literature Review
Open Access NM
193
chionosis, and Echinococcus cysts.
REFERENCES
[1] M. Gemmell, Z. Matyas, Z. Pawlowsky and E. J. L.
Soulsby, “Guidelines for Surveillance and Control of
Taeniasis/Cysticercosis, Vol. 83,” World Health Organi-
zation, Switzerland, 1983, p. 49.
[2] G. Roman, J. Sotelo, O. Del Brutto, et al., “A Proposal to
Declare Neurocysticercosis an International Reportable
Disease,” Bulletin of the World Health Organization, Vol.
78, No. 3, 2000, pp. 399-406
[3] K. Hutcheson III, M. Kalafian, I. Taylor, J. Sagel and B.
Clyburn, “Neurocysticercosis,” Southern Medical Journal,
Vol. 7, 2000, pp. 666-668.
[4] M. T. Wallin and J. F. Kurtzke, “Neurocysticercosis in
the United States: Review of an Important Emerging In-
fection,” Neurology, Vol. 63, No. 9, 2004, pp. 1559-1564.
http://dx.doi.org/10.1212/01.WNL.0000142979.98182.FF
[5] O. H. Del Brutto, J. Sotelo, “Neurocysticercosis: An Up-
date,” Clinical Infectious Disease, Vol. 10, No. 6, 1988,
pp. 1075-1087.
[6] J. G. Burneo, I. Plener and H. H. Garcia, “Neurocysticer-
cosis in a Patient in Canada,” CMAJ, Vol. 180, No. 6,
2009, pp. 639-642.
[7] H. H. Garcia and O. H. Del Brutto “Neurocysticercosis:
Updated Concepts about an Old Disease,” The Lancet
Neurology, Vol. 4, No. 10, 2005, pp. 653-661.
http://dx.doi.org/10.1016/S1474-4422(05)70194-0
[8] J. A. Serpa, L. S. Yancey and A. C. White Jr., “Advances
in the Diagnosis and Management of Neurocysticercosis,”
Expert Review of Anti-infective Therapy, Vol. 4, No. 6,
2006, pp. 1051-1061.
http://dx.doi.org/10.1586/14787210.4.6.1051
[9] H. H. Garcia, R. Gilman, M. Martinez, et al., “Cysticer-
cosis as a Major Cause of Epilepsy in Peru. The Cysti-
cercosis Working Group in Peru (CWG),” Lancet, Vol.
341, No. 8839, 1993, pp. 197-200.
http://dx.doi.org/10.1016/0140-6736(93)90064-N
[10] O. H. Del Brutto, V. Rajshekhar, A. C. White Jr., et al.,
“Proposed Diagnostic Criteria for Neurocysticercosis,”
Neurology, Vol. 57, No. 2, 2001, pp. 177-183.
http://dx.doi.org/10.1212/WNL.57.2.177
[11] J. A. Serpa, A. Moran, J. C. Goodman, T. P. Giordano,
and A. C. White Jr, “Neurocysticercosis in the HIV Era:
A Case Report and Review of the Literature,” American
Journal of Tropical Medicine and Hygiene, Vol. 77, No.
1, 2007, pp. 113-117.
[12] S. Remy, MSN, RN, CEN and Vineland, “A 44-Year-Old
Man with Neurocysticercosis,” Journal of Emergency
Nursing, Vol. 35, No. 4, 2009, pp. 348-349.
http://dx.doi.org/10.1016/j.jen.2008.04.024
[13] S. A. Cudlip, P. R. Wilkins and H. T. Marsh, “Endo-
scopic Removal of a Third Ventricular Cysticercal Cyst,”
British Journal of Neurosurgery, Vol. 12, No. 5, 1998, pp.
452-454. http://dx.doi.org/10.1080/02688699844691
[14] R. Kelley, D. H. Duong and G. E. Locke, “Characteristics
of Ventricular Shunt Malfunctions among Patients with
Neurocysticercosis,” Neurosurgery, Vol. 50, No. 4, 2002,
pp. 757-762.
http://dx.doi.org/10.1097/00006123-200204000-00014
[15] M. Bergsneider, L. T. Holly, J. H. Lee, W. A. King and J.
G. Frazee, “Endoscopic Management of Cysticercal cysts
within the Lateral and Third Ventricles,” Journal of Neu-
rosurgery, Vol. 92, No. 1, 2000, pp. 14-23.
http://dx.doi.org/10.3171/jns.2000.92.1.0014
[16] V. Kalra, D. Mishra, A.Suri, R. Seth and A. Garg, “Intra-
ventricular Neurocysticercosis,” The Indian Journal of
Pediatrics, Vol. 76, No. 4, 2009, pp. 420-423.
[17] H. H. García, C. A. Evans, T. E. Nash, O. M. Takayana-
gui, A. C. White, D. Botero, V. Rajshekhar, V. C.Tsang,
et al., “Current Consensus Guidelines for Treatment of
Neurocysticercosis,” Clinical Microbiology Reviews, Vol.
15, No. 4, 2002, pp. 747-756.
http://dx.doi.org/10.1128/CMR.15.4.747-756.2002
[18] A. Escobar and K. M. Weidenheim, “The Pathology of
Neurocysticercosis,” In: G. Singh and S. Prabhakar, Eds.,
Taenia solium Cysticercosis: From Basic to Clinical Sci-
ence, United Kingdom CABI Publishing, Wallingford,
2002, pp. 289-305.
http://dx.doi.org/10.1079/9780851996288.0289
[19] A. C. White Jr., “Neurocysticercosis: Updates on Epide-
miology, Pathogenesis, Diagnosis, and Management,”
Annual Review of Medicine, Vol. 51, 2000, pp. 187-206.
http://dx.doi.org/10.1146/annurev.med.51.1.187
[20] A. Carpio, “Neurocysticercosis: An Update,” The Lancet
Infectious Diseases, Vol. 2, No. 12, 2002, pp. 751-762.
http://dx.doi.org/10.1016/S1473-3099(02)00454-1
[21] M. P. Earnest, L. B. Reller, C. M. Filley and A. J. Grek,
“Neurocysticercosis in the United States: 35 Cases and a
Review,” Reviews of Infectious Diseases, Vol. 9, No. 5,
1987, pp. 961-979.
http://dx.doi.org/10.1093/clinids/9.5.961
[22] J. E. Pittella, “Neurocysticercosis,” Brain Pathology, Vol.
7, No. 1, 1997, pp. 681-693.
http://dx.doi.org/10.1111/j.1750-3639.1997.tb01083.x
[23] H. H. García, A. E. Gonzalez, C. A. Evans and R. H.
Gilman, “Cysticercosis Working Group in Peru. Taenia
solium Cysticercosis,” Lancet, Vol. 362, No. 9383, 2003,
pp. 547-556.
http://dx.doi.org/10.1016/S0140-6736(03)14117-7
[24] C. M. DeGio rgio, M. T. Me di na , R. Dur ón , C. Zee a nd S.
P. Escueta, “Neurocysticerc osis,” Epilepsy Currents, Vol.
4, No. 3, 2004, pp. 107-111.
http://dx.doi.org/10.1111/j.1535-7597.2004.43008.x
[25] D. Scharf, “Neurocysticercosis: Two Hundred Thirty-
Eight Cases from a Ca lifornia Hospit al,” Archives of Neu-
rology, Vol. 45, No. 7, 1988, pp. 777-780.
http://dx.doi.org/10.1001/archneur.1988.00520310087022